Isomorphic Labs Secures $600 Million to Advance A.I. in Drug Discovery
Isomorphic Labs, Google’s A.I. drug division, has raised $600 million, led by Thrive Capital. This funding highlights their advancements in drug design using A.I., particularly with technologies like AlphaFold, which …
Isomorphic Labs Secures $600 Million to Advance A.I. in Drug Discovery Read More